France· FR:62907143
PRIMAQUINE SANOFI 15 mg, comprimé pelliculé
A primaquine product containing phosphate de primaquine, registered in France by SANOFI WINTHROP INDUSTRIE. The same ATC class is registered in 7 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Primaquine is registered in 7 of 19 countries.
Countries holding a registration under ATC P01BA03 (primaquine), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 4 of them publish a price we can compare per daily dose
Primaquine · ATC P01BA03
7 / 19 countries
- Canada
- Czechiaprice
- Franceprice
- Japan
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- PHOSPHATE DE PRIMAQUINE
- Manufacturer
- SANOFI WINTHROP INDUSTRIE
- Country
- France (FR)
- ATC code
- P01BA03
- ATC class
- Primaquine
- Defined daily dose
- 15 mg, O
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip1334009302932251 flacon polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 14 comprimés reconditionnés
- cip1334009551013691 flacon polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 100 comprimés avec kit de reconditionnement
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
348 interactions on record for primaquine.
Graded by severity as the source publishes them — 88 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Primaquine · interactions on record
348 records
- 88 severe
- 255 moderate
- 5 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Primaquine in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesPrimaquine PhosphatePD-Rx Pharmaceuticals, Inc.
- CzechiaPRIMAQUINE
- United KingdomPrimaquine 15mg tabletsImported (United States)
- CanadaPRIMAQUINESANOFI-AVENTIS CANADA INC
- Japanプリマキンリン酸塩サノフィ
- NorwayPrimaquine phosphate sanofiSanofi-Synthelabo
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Cyprus · Primaquine Remedica
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c57747f8-d786-4a3e-b8f8-cd69c02abdb8 GET /v1/drugs/c57747f8-d786-4a3e-b8f8-cd69c02abdb8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62907143",
"date_amm": "2024-05-27",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "PHOSPHATE DE PRIMAQUINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about primaquine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.